Dyne Therapeutics News

Dyne Therapeutics | 8-K: Current report

Nov 12 09:39 ET

Dyne Therapeutics | 8-K: Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12 09:27 ET

Dyne Therapeutics | 8-K: Current report

Sep 3 07:21 ET

Dyne Therapeutics | 8-K: Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 12 17:17 ET

Dyne Therapeutics | 8-K: Current report

May 24 17:02 ET

Dyne Therapeutics | 8-K: Current report

May 22 08:04 ET

Dyne Therapeutics | 8-K: Current report

May 20 07:40 ET

Dyne Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 2 16:28 ET

Dyne Therapeutics | 8-K: Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

May 2 16:20 ET

Dyne Therapeutics | DEFA14A: Others

Apr 5 16:24 ET

Dyne Therapeutics | DEF 14A: Definitive information statements

Apr 5 16:20 ET

Dyne Therapeutics | 8-K: Current report

Mar 25 07:43 ET

Dyne Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Mar 5 08:22 ET

Dyne Therapeutics | 8-K: Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

Mar 5 07:42 ET

Dyne Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 5 07:42 ET

Dyne Therapeutics | 8-K: Current report

Jan 5 00:00 ET

Dyne Therapeutics | 8-K: Current report

Jan 4 00:00 ET

Dyne Therapeutics | 8-K: Current report

Jan 3 00:00 ET

Dyne Therapeutics | 8-K: Dyne Therapeutics Reports Third Quarter 2023 Financial Results and Provides Update on Significant Progress for ACHIEVE and DELIVER Trials and Upcoming Clinical Milestones

Oct 30, 2023 07:36 ET

Dyne Therapeutics | 8-K: Dyne Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights

Aug 3, 2023 07:35 ET